Connect with NCQA

twitter linkedin facebook google+ youtube pinterest

Report an Error

Use NCQA’s Feedback Form to report a broken link, or content error.

Immunizations for Adolescents

This HEDIS Measure

Assesses adolescents 13 years of age who had one dose of meningococcal vaccine, one Tdap vaccine and the complete human papillomavirus vaccine series by their 13th birthday.

So What?

Vaccines are a safe and effective way to protect adolescents against potential deadly diseases.1 Receiving recommended vaccinations is the best defense against vaccine-preventable diseases, including meningococcal meningitis, tetanus, diphtheria, pertussis (whooping cough) and human papillomavirus. These are serious diseases that can cause breathing difficulties, heart problems, nerve damage, pneumonia, seizures, cancer—and even death.2 

References

1. National Foundation for Infectious Diseases. AdolescentVaccination.org. 2013. “10 Reasons to be Vaccinated.” http://adolescentvaccination.org/10-reasons 
2. CDC. 2017. “2017 Recommended Immunizations for Children 7–18 Years Old.” https://www.cdc.gov/vaccines/who/teens/downloads/parent-version-schedule-7-18yrs.pdf  


Note: The HPV rate that was added to the IMA measure was previously a separate measure in HEDIS. The HPV vaccine was added to the IMA measure in HEDIS 2017 as a separate rate. It is not a new measure for HEDIS 2017, but is a new rate collected for the IMA measure, which now includes males and females. HPV rates in HEDIS 2017 are not trendable.

tables
Meningococcal (MCV4)
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016  78.6 72.4  77.4 -- --
2015 76.0 67.5 74.8
2014 72.7 64.3 73.4
2013 69.5 60.6 71.9
2012 66.0 57.1 69.4
2011 61.9 51.4 63.2
2010 55.2 43.8 56.3
Tetanus, Diphtheria, Acellular Pertussis (TDAP/TD)
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016  87.0  81.6 84.9  -- --
2015 85.6 77.5 83.4
2014 84.0 76.4 83.7
2013 81.5 73.0 83.6
2012 79.2 69.9 81.3
2011 77.0 65.4 75.8
2010 69.5 55.3 67.8
Human Papillomavirus Vaccine for Adolescents
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016  16.7 13.9 22.7 -- --
Adolescent Immunization Combination 1 (Meningococcal, TDAP/TD)
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016  77.0 70.3  75.1  -- --
2015 74.2 64.9 72.7
2014 70.8 61.9 71.4
2013 67.5 58.2 70.2
2012 63.7 54.3 67.2
2011 59.4 48.2 60.5
2010 51.6 39.4 52.2
ADOLESCENT IMMUNIZATION COMBINATION 2 (MENINGOCOCCAL, TDAP/TD, HPV)
Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 15.5 12.6 20.8 -- --